Not checkedNot checked for notices yet.
A L833V/H835L EGFR variant lung adenocarcinoma with skin metastasis: A case report and literature review
Xian Yang, Yang Yao, Qing Zhu
Heliyon · 2022
doi:10.1016/j.heliyon.2022.e12080 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The co-occurrence of two or more rare variants, known as compound variants, is rare in non-small cell lung carcinoma with epidermal growth factor receptor (EGFR) variants, and the compound variant L833V/H835L in exon 21 of EGFR is extremely rare. There is very little evidence regarding its treatment. Herein, we report a case of an advanced lung adenocarcinoma patient with cutaneous metastases. Next generation sequencing detected a combination variant of EGFR exon 21 L833V/H835L. To our surprise, our patient had almost complete remission of skin symptoms after 1 month of oral gefitinib (250 mg/d qd) treatment with less skin toxicity. At the time of this report submission, the last CT scan confirmed that the patient had achieved partial response. To date, the patient has achieved a remarkable result with a progression-free survival of 18 + months. The presentation of this case and a literature review suggest that tailored therapeutic interventions are available for this subset of patients.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.